ArticleJournal for immunotherapy of cancer2023

Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma.

Ming Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.